- Home
- PGNY vs RDY Comparison
PGNY vs RDY Comparison
Compare PGNY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGNY
- RDY
- Stock Information
- Founded
- PGNY 2008
- RDY 1984
- Country
- PGNY United States
- RDY India
- Employees
- PGNY N/A
- RDY N/A
- Industry
- PGNY Misc Health and Biotechnology Services
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- PGNY Health Care
- RDY Health Care
- Exchange
- PGNY Nasdaq
- RDY Nasdaq
- Market Cap
- PGNY 1.8B
- RDY 2.1B
- IPO Year
- PGNY 2019
- RDY N/A
- Fundamental
- Price
- PGNY $20.52
- RDY $14.38
- Analyst Decision
- PGNY Buy
- RDY Buy
- Analyst Count
- PGNY 9
- RDY 1
- Target Price
- PGNY $22.71
- RDY $17.00
- AVG Volume (30 Days)
- PGNY 1.1M
- RDY 1.6M
- Earning Date
- PGNY 05-08-2025
- RDY 05-09-2025
- Dividend Yield
- PGNY N/A
- RDY 0.67%
- EPS Growth
- PGNY N/A
- RDY 1.46
- EPS
- PGNY 0.57
- RDY 0.79
- Revenue
- PGNY $1,213,181,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- PGNY $5.72
- RDY $10.24
- Revenue Next Year
- PGNY $11.43
- RDY N/A
- P/E Ratio
- PGNY $36.22
- RDY $18.18
- Revenue Growth
- PGNY 9.46
- RDY 16.61
- 52 Week Low
- PGNY $13.39
- RDY $12.26
- 52 Week High
- PGNY $30.42
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- PGNY 36.36
- RDY 61.11
- Support Level
- PGNY $21.00
- RDY $14.25
- Resistance Level
- PGNY $22.70
- RDY $14.54
- Average True Range (ATR)
- PGNY 0.83
- RDY 0.23
- MACD
- PGNY -0.22
- RDY 0.03
- Stochastic Oscillator
- PGNY 4.97
- RDY 87.96
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.